Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
Articles > Article · 2024
Authors: Süreyya Yiğit Kaya, Yaşa Gül Mutlu, Ümit Yavuz Malkan, Özgür Mehtap, Fatma KEKLİK KARADAĞ, Gülten Korkmaz, Tuğrul Elverdi, Güray SAYDAM, Gülsüm Özet, Muhlis Cem Ar, Elif Melek, Senem Maral, Leylagül Kaynar, Ömür Gökmen Sevindik
Leukemia Research, International, WoS, 2024, vol 140, pp 107495-107495